Cafepharma Today

October 24 2024 - Weight-loss drugs didn't curb health costs within two years
Weight-loss drugs didn't curb health costs within two years
GSK answers Pfizer's RSV approval with data targeting matching nod in younger adults
Why pharma megamergers may become a relic of the past
Lundbeck planning for four novel drugs in phase 3 in 2026
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Pozen's 3Q loss bigger than expected
Bizjournals.com
Wednesday, October 29, 2008 - 10:18am
tags:
Sepracor Putting Cash to Work
Yahoo/Zacks.com
Wednesday, October 29, 2008 - 10:18am
tags:
Cephalon reports profit spike on charges, raises outlook
Marketwatch
Wednesday, October 29, 2008 - 9:35am
tags:
Pfizer Needs Isis More Than Isis Needs Pfizer
Seeking Alpha
Wednesday, October 29, 2008 - 9:33am
tags:
Novartis: Rasilez HCT approved to treat high blood pressure
Marketwatch
Wednesday, October 29, 2008 - 9:32am
tags:
Study: Schering-Plough anti-anesthesia drug brings much faster recovery than the standard one
Yahoo/AP
Wednesday, October 29, 2008 - 9:31am
tags:
J&J's Prevention Cure
Forbes
Wednesday, October 29, 2008 - 9:26am
tags:
Alcon Takes A Poke In The Eye
Investopedia
Wednesday, October 29, 2008 - 9:25am
tags:
WSJ: Wyeth to curb research on women's health drugs
Marketwatch
Wednesday, October 29, 2008 - 9:24am
tags:
[video] Mad About Options: J&J in Review
The Street.com
Wednesday, October 29, 2008 - 9:14am
tags:
Vertex Pharma Promising, Volatile
Yahoo/Zacks.com
Wednesday, October 29, 2008 - 9:14am
tags:
Bayer Third-Quarter Net Fell 76.4% on Tax Benefit
Bloomberg
Wednesday, October 29, 2008 - 9:00am
tags:
J&J Units Must Pay $13 Million Over Pain-Patch Death, Jury Says
Bloomberg
Wednesday, October 29, 2008 - 8:59am
tags:
J&J deal marks preventive health move
Fierce Pharma
Tuesday, October 28, 2008 - 11:39am
tags:
When will the deluge of M&As hit?
Fierce Pharma
Tuesday, October 28, 2008 - 11:39am
tags:
Sepracor is seeking drug development partner
Boston Globe, MA
Tuesday, October 28, 2008 - 11:37am
tags:
Sepracor 3rd-quarter profit slides 51 percent on increased operating expenses
Yahoo/AP
Tuesday, October 28, 2008 - 11:35am
tags:
Rigel shares plunge on arthritis drug study
Marketwatch
Tuesday, October 28, 2008 - 11:34am
tags:
Clinical Data to acquire Avalon Pharmaceuticals
Marketwatch
Tuesday, October 28, 2008 - 11:28am
tags:
Provectus Announces Completion of Phase 1 Clinical Trial of PV-10 in Recurrent Breast Cancer
Yahoo
Tuesday, October 28, 2008 - 11:00am
tags:

Pages

Latest CP Wire Articles

Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility

Latest Pharmagather Articles

A Pfight at Pfizer
In the Pipeline
Clinical Trial Volunteers, And Others
In the Pipeline
The 340B Program Reached $66 Billion in 2023—Up 23% vs. 2022: Analyzing the Numbers and HRSA’s Curious Actions
Drug Channels
HCN in Acetonitrile, You Say?
In the Pipeline
Informa Connect’s Trade and Channel Strategies
Drug Channels
AI Does Not Make It Easy
In the Pipeline
The Promise of a Direct-to-Patient Model—Breaking Down What’s Really Needed for Better Patient Access
Drug Channels
Accelerated Approval: What Is It Accomplishing?
In the Pipeline
Cleaning up "Scientific Reports": Can It Be Done?
In the Pipeline

Latest Jobs

Account Manager-Orlando, FL-Ophthalmics
Maitland, Florida, 32794
Sun Pharmaceutical Industries, Inc.
Account Manager-Orlando, FL-Ophthalmics
Alafaya, Florida
Sun Pharmaceutical Industries, Inc.
Account Manager-Orlando, FL-Ophthalmics
Union Park, Florida
Sun Pharmaceutical Industries, Inc.
Account Manager-Houston West-Ophthalmics
Bunker Hill Village, Texas
Sun Pharmaceutical Industries, Inc.
Account Manager-Phoenix, AZ-Oncology
Paradise Valley, Arizona, 85253
Sun Pharmaceutical Industries, Inc.
Account Manager-Houston West-Ophthalmics
Pasadena, Texas, 77505
Sun Pharmaceutical Industries, Inc.
Account Manager-Houston West-Ophthalmics
Cloverleaf, Texas
Sun Pharmaceutical Industries, Inc.
Account Manager-Orlando, FL-Ophthalmics
Gotha, Florida, 34734
Sun Pharmaceutical Industries, Inc.
Account Manager-Orlando, FL-Ophthalmics
Longwood, Florida, 32791
Sun Pharmaceutical Industries, Inc.
Territory Manager - Medical Dermatology, Richmond VA
Richmond
Sun Pharmaceutical Industries, Inc.
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information